Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors.
作者信息
Rajeh Ahmad, Roster Katie, Reynolds Kerry L, LeBoeuf Nicole R, Sullivan Ryan J, Kwatra Shawn G, Semenov Yevgeniy R
机构信息
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
出版信息
J Eur Acad Dermatol Venereol. 2025 Jul;39(7):e597-e599. doi: 10.1111/jdv.20484. Epub 2024 Dec 20.
Abstract
摘要
相似文献
1
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors.免疫检查点抑制剂治疗后皮肤免疫相关不良事件的季节和地理差异。
J Eur Acad Dermatol Venereol. 2025 Jul;39(7):e597-e599. doi: 10.1111/jdv.20484. Epub 2024 Dec 20.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Treatment-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors in advanced lung cancer: A systematic review and meta-analysis.免疫检查点抑制剂联合血管生成抑制剂治疗晚期肺癌的相关不良反应：系统评价和荟萃分析。
Int Immunopharmacol. 2023 Oct;123:110785. doi: 10.1016/j.intimp.2023.110785. Epub 2023 Aug 21.
4
Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysis.免疫检查点阻断相关的皮肤不良反应：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2021 Jul;163:103376. doi: 10.1016/j.critrevonc.2021.103376. Epub 2021 Jun 2.
5
Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials.不可切除转移性皮肤黑色素瘤中免疫检查点靶向治疗：抗CTLA-4和抗PD-1药物试验的系统评价和荟萃分析
Cancer Med. 2016 Jul;5(7):1481-91. doi: 10.1002/cam4.732. Epub 2016 May 11.
6
Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review.血管内皮生长因子靶向治疗在免疫检查点抑制剂预处理的肾细胞癌患者中的应用：系统文献回顾。
Cancer Treat Rev. 2024 Jan;122:102652. doi: 10.1016/j.ctrv.2023.102652. Epub 2023 Nov 4.
7
Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.免疫检查点抑制剂治疗的癌症患者接种 COVID-19 疫苗后的血清学反应和免疫相关不良事件：系统评价和荟萃分析。
Rev Med Virol. 2024 Jan;34(1):e2495. doi: 10.1002/rmv.2495. Epub 2023 Nov 28.
8
Association of Sex with Survival and Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Single-Center Experience in Türkiye.接受免疫检查点抑制剂治疗的非小细胞肺癌患者的性别与生存及不良事件的关联：土耳其的单中心经验
Med Sci Monit. 2025 Apr 1;31:e947817. doi: 10.12659/MSM.947817.
9
Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂不良反应的特征、管理和预后意义：系统评价。
Actas Dermosifiliogr. 2022 Apr;113(4):376-387. doi: 10.1016/j.ad.2021.09.005. Epub 2021 Dec 31.
10
Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis.免疫检查点抑制剂相关肺部不良事件的比较：临床研究的回顾性分析和网状Meta分析
BMC Med. 2024 Feb 19;22(1):75. doi: 10.1186/s12916-024-03285-3.
本文引用的文献
1
Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis.含免疫检查点抑制剂方案中皮肤免疫相关不良事件及结局的发生率：一项系统评价和荟萃分析
Cancers (Basel). 2024 Jan 13;16(2):340. doi: 10.3390/cancers16020340.
2
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.皮肤免疫相关不良反应与接受免疫检查点抑制剂治疗的晚期癌症患者的总生存期延长相关：一项多机构队列研究。
J Am Acad Dermatol. 2023 May;88(5):1024-1032. doi: 10.1016/j.jaad.2022.12.048. Epub 2023 Feb 2.
3
Seasonal variation in effect of anti-PD-1 initiation on overall survival among patients with advanced melanoma.抗PD-1起始治疗对晚期黑色素瘤患者总生存期影响的季节性变化
Pigment Cell Melanoma Res. 2023 Mar;36(2):224-231. doi: 10.1111/pcmr.13072. Epub 2022 Nov 14.
4
Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration.通过国际疾病分类编码和药物管理识别皮肤免疫相关不良事件。
JAAD Int. 2022 Aug 18;9:112-115. doi: 10.1016/j.jdin.2022.08.001. eCollection 2022 Dec.
5
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.晚期癌症患者的皮肤和非皮肤免疫相关不良事件模式。
JAMA Dermatol. 2021 May 1;157(5):577-582. doi: 10.1001/jamadermatol.2021.0326.
6
The Migratory Properties and Numbers of T Regulatory Cell Subsets in Circulation Are Differentially Influenced by Season and Are Associated With Vitamin D Status.循环中调节性 T 细胞亚群的迁移特性和数量受季节的影响而不同，并与维生素 D 状态相关。
Front Immunol. 2020 May 19;11:685. doi: 10.3389/fimmu.2020.00685. eCollection 2020.
7
The calendar of epidemics: Seasonal cycles of infectious diseases.传染病年历：传染病的季节性周期
PLoS Pathog. 2018 Nov 8;14(11):e1007327. doi: 10.1371/journal.ppat.1007327. eCollection 2018 Nov.
Zotero 插件